AuntMinnie

JANUARY 26, 2024

In a comparative imaging trial, fibroblast activation protein inhibitor (FAPI)-PET/CT outperformed FDG-PET/CT in detecting primary tumors in patients with head and neck cancer, according to a study published January 25 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine.

Nuclear Medicine 122

Nuclear Medicine Imaging MRI Diagnostic 122

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

JUNE 29, 2023

christine.book Thu, 06/29/2023 - 12:17 June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, SNMMI 2023 , found that personalized dosing of men with prostate cancer resulted in improved patient outcomes. Approved by the U.S. Patients at St.

Nuclear Medicine 83

Nuclear Medicine Hospital Disease Clinic 83

Imaging Technology

JULY 26, 2023

The findings are described in European Urology and were presented at the American Society of Clinical Oncology and Society of Nuclear Medicine & Molecular Imaging annual meetings in 2022. For more information: [link] Wednesday, July 26, 2023 - 20:36

Nuclear Medicine 73

Nuclear Medicine Imaging Disease Clinic 73

Imaging Technology

MAY 31, 2023

“We can’t treat what we don’t see, which is why we require precise image quality to help diagnose, plan treatment for, and monitor disease,” explains Prof. Flavio Forrer , MD, PhD, Chairman of Nuclear Medicine in the Division of Radiology and Nuclear Medicine at Kantonsspital St. Gallen in Switzerland [vii].

Nuclear Medicine 83

Nuclear Medicine Healthcare Healthcare IT 83

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

AuntMinnie

APRIL 15, 2024

FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of Nuclear Medicine. FAPI-PET either confirmed or ruled out the disease in all cases, the group found.

Nuclear Medicine 122

Nuclear Medicine PET Scan Hospital Clinic 122

Imaging Technology

JUNE 28, 2023

milla1cf Wed, 06/28/2023 - 20:28 June 28, 2023 — GE HealthCare is set to unveil SIGNA PET/MR AIR [i] , at the Society of Nuclear Medicine and Molecular Imaging ( SNMMI) 2023 annual meeting. The recent approval of drugs with disease modifying potential require additional imaging of patients with both MR and PET. Feb 3, 2022.

Healthcare 94

Healthcare Healthcare Disease Nuclear Medicine 94

Imaging Technology

JUNE 19, 2023

Dr. Scholz joined NorthStar in 2021, and was promoted to President and Chief Operating Officer (COO) in 2022. Our fast-growing portfolio encompasses promising therapeutic radioisotopes, specialty SPECT imaging agents and collaborative research for the use of therapeutic radiopharmaceuticals to treat a range of potential disease states.

Medical 80

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 80

Imaging Technology

APRIL 3, 2023

These capabilities will help them develop and deliver products with the potential to improve care for even more patients with serious disease. “In Mr. Merrick concluded, “This is a very exciting and dynamic time for NorthStar and all those involved in nuclear medicine. Mo-99 production without the use of uranium.

Medical 82

Medical Radiopharmaceuticals Pharmaceutical Radiation 82